Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic ratsQingmiao Shao, Tong Liu, Lei Meng et al.|Cardiovascular Diabetology|2019Cited by 296
Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysisTong Liu, Guangping Li, Κonstantinos P. Letsas et al.|EP Europace|2015Cited by 48
Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary interventionXi‐Yong Yu, Shilong Zhong, Zhihong Chen et al.|EuroIntervention|2013Cited by 40